Literature DB >> 32035077

Gender differences in LDL and HDL subfractions in atherogenic and nonatherogenic phenotypes.

Ingrid Zitnanova1, Stanislav Oravec2, Maria Janubova1, Katarina Konarikova1, Monika Dvorakova1, Lucia Laubertova1, Maria Kralova3, Martin Simko4, Jana Muchova5.   

Abstract

OBJECTIVES: The aim of our study was to examine the role of low density lipoprotein (LDL)-subfractions in individuals with the atherogenic and non-atherogenic phenotype and the gender differences in lipoprotein subfractions including small dense LDL (sdLDL) and small high density lipoprotein (sHDL) subfractions representing the most atherogenic lipoprotein subfractions. DESIGN &
METHODS: 35 persons in the atherogenic group (AG) (with sdLDL3-7 subfractions ≥6 mg/dl) and 104 individuals in the non-atherogenic group (NAG) (sdLDL3-7 subfractions <6 mg/dl) were included in our study. To analyze plasma lipoprotein subfractions, a polyacrylamide gel electrophoresis-the Lipoprint system was used.
RESULTS: Males compared to females in the AG had significantly higher levels of atherogenic lipoprotein subfractions such as HDL8, HDL9 and HDL10. All participants in AG had significantly lower levels of intermediate density lipoprotein IDL-A than those in NAG but significantly higher levels of IDL-B and IDL-C. Males in the AG compared to NAG had significantly lower levels of LDL1 and higher levels of LDL2 and LDL3-7 subfractions. In the NAG LDL2 positively correlated with sHDL subfractions while in the AG with the large HDL subfraction.
CONCLUSION: Results of our study demonstrate more atherogenic profile in males compared to females and a double role of LDL2 subfraction in the atherogenic process depending on the phenotype (atherogenic/non-atherogenic) of individuals.
Copyright © 2020 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherogenesis; HDL-subfractions; LDL-subfractions

Mesh:

Substances:

Year:  2020        PMID: 32035077     DOI: 10.1016/j.clinbiochem.2020.02.002

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Semi-parametric Estimation of Biomarker Age Trends with Endogenous Medication Use in Longitudinal Data.

Authors:  Andrew J Spieker; Joseph A C Delaney; Robyn L McClelland
Journal:  Obs Stud       Date:  2021-05-27

2.  Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease.

Authors:  Negar Sarmadi; Hossein Poustchi; Fatemeh Ali Yari; Amir Reza Radmard; Sara Karami; Abbas Pakdel; Parisa Shabani; Ali Khaleghian
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

Review 3.  Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

Authors:  Susana Coimbra; Flávio Reis; Maria João Valente; Susana Rocha; Cristina Catarino; Petronila Rocha-Pereira; Maria Sameiro-Faria; Elsa Bronze-da-Rocha; Luís Belo; Alice Santos-Silva
Journal:  Biomedicines       Date:  2021-05-16

4.  Lipid Profile, Lipoprotein Subfractions, and Fluidity of Membranes in Children and Adolescents with Depressive Disorder: Effect of Omega-3 Fatty Acids in a Double-Blind Randomized Controlled Study.

Authors:  Barbora Katrenčíková; Magdaléna Vaváková; Iveta Waczulíková; Stanislav Oravec; Iveta Garaiova; Zuzana Nagyová; Nataša Hlaváčová; Zdenka Ďuračková; Jana Trebatická
Journal:  Biomolecules       Date:  2020-10-08

5.  Phytonutrients of Bitter Apricot Seeds Modulate Human Lipid Profile and LDL Subfractions in Adults with Elevated Cholesterol Levels.

Authors:  Jana Kopčeková; Anna Kolesárová; Marianna Schwarzová; Anton Kováčik; Jana Mrázová; Martina Gažarová; Petra Lenártová; Peter Chlebo; Adriana Kolesárová
Journal:  Int J Environ Res Public Health       Date:  2022-01-13       Impact factor: 3.390

6.  Relationship between subclasses low-density lipoprotein and carotid plaque.

Authors:  Zhanhai Pan; Huiwen Guo; Qingqing Wang; Sha Tian; Xiaoxuan Zhang; Chengbo Li; Zheng Ma
Journal:  Transl Neurosci       Date:  2022-03-03       Impact factor: 1.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.